June 11, 2024 June 11, 2024Categories From the Co-ChairsFrom the Co-Chairs, June 2024A Spring Group Meeting recap; a milestone for TMIST; a new myeloMATCH treatment trial
June 11, 2024 June 11, 2024Categories Active Clinical TrialsNow Enrolling: myeloMATCH Treatment Trial MM1OA-EA02 for Older Patients with Newly Diagnosed FLT3-Mutated Acute Myeloid LeukemiaThis phase 2 study is testing two variations of the triplet combination of azacitidine, venetoclax, and gilteritinib compared to standard therapy
June 11, 2024 June 11, 2024Categories PeopleECOG-ACRIN Names University of Wisconsin’s Dustin Deming as Its Young Investigator of the YearDustin A. “Dusty” Deming, MD, is the young investigator of the year for the ECOG-ACRIN Cancer Research Group
June 11, 2024 June 11, 2024Categories PeopleHeather Wakelee Honored with ECOG-ACRIN’s Remarkable Mentor to Women in Oncology AwardThe group is recognizing Dr. Wakelee for her sustained commitment to developing women’s careers in cancer medicine and advancing women investigators in ECOG-ACRIN
June 11, 2024 June 11, 2024Categories Trial ResultsTrial Results: ECOG-ACRIN Research Round-Up – ASCO 2024 HighlightsSummaries of five ECOG-ACRIN trials presented at the 2024 American Society of Clinical Oncology Annual Meeting
June 11, 2024 June 11, 2024Categories News in BriefNews in Brief, June 2024Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
June 13, 2024 June 13, 2024Categories Coming SoonNow Enrolling: EA7222 for Patients with Advanced Soft Tissue SarcomaThis randomized phase 3 trial is comparing treatment with chemotherapy alone or with immunotherapy